There is no standard treatment for head and neck cancer with SMARCB1-deficient tumors, and multidisciplinary treatments, such as surgery, cisplatin-based chemotherapy, and radiation, have been performed [2,10]. This evidence concerns the gene SMARCB1 and head and neck cancer.